Last reviewed · How we verify

Alfacalcidol tablets

Chinese SLE Treatment And Research Group · FDA-approved active Small molecule Quality 2/100

Alfacalcidol tablets is a Small molecule drug developed by Chinese SLE Treatment And Research Group. It is currently FDA-approved.

At a glance

Generic nameAlfacalcidol tablets
SponsorChinese SLE Treatment And Research Group
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Alfacalcidol tablets

What is Alfacalcidol tablets?

Alfacalcidol tablets is a Small molecule drug developed by Chinese SLE Treatment And Research Group.

Who makes Alfacalcidol tablets?

Alfacalcidol tablets is developed and marketed by Chinese SLE Treatment And Research Group (see full Chinese SLE Treatment And Research Group pipeline at /company/chinese-sle-treatment-and-research-group).

What development phase is Alfacalcidol tablets in?

Alfacalcidol tablets is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing